Log in to save to my catalogue

Administration of Warfarin Inhibits the Development of Cerulein-Induced Edematous Acute Pancreatitis...

Administration of Warfarin Inhibits the Development of Cerulein-Induced Edematous Acute Pancreatitis...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9c20fa3a03514975a37bf13a8936122e

Administration of Warfarin Inhibits the Development of Cerulein-Induced Edematous Acute Pancreatitis in Rats

About this item

Full title

Administration of Warfarin Inhibits the Development of Cerulein-Induced Edematous Acute Pancreatitis in Rats

Publisher

Switzerland: MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2023-06, Vol.13 (6), p.948

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Acute pancreatitis (AP) is a severe disease with high morbidity and mortality in which inflammation and coagulation play crucial roles. The development of inflammation leads to vascular injury, endothelium and leukocytes stimulation, and an increased level of tissue factor, which results in the activation of the coagulation process. For this reason...

Alternative Titles

Full title

Administration of Warfarin Inhibits the Development of Cerulein-Induced Edematous Acute Pancreatitis in Rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9c20fa3a03514975a37bf13a8936122e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9c20fa3a03514975a37bf13a8936122e

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom13060948

How to access this item